 |
|
Intravitreal Anti-vascular Endothelial Growth Factor Injections to Treat Neovascular Age-related Macular Degeneration: Long-term Treatment Outcomes.
Yu Jeong Park, Gi Sung Son, Yoon Jeon Kim, June Gone Kim, Young Hee Yoon, Joo Yong Lee
J Korean Ophthalmol Soc. 2018;59(12):1142-1151. Published online 2018 Dec 15 DOI: https://doi.org/10.3341/jkos.2018.59.12.1142
|
|
Citations to this article as recorded by
 Comparison of Real-world Treatment Outcomes between Type 1 and Type 2 Choroidal Neovascularization
Mi Jeong Kim, Ki Seok Kim, Hee Jung Yang
Journal of Retina.2022; 7(2): 98. CrossRef Therapeutic Efficacy of Intravitreal Dexamethasone Implant in Korean Patients with Non-infectious Uveitis
Jae Yong Han, Dong Hyun Lee, Jung Dong Kim, Eun Young Choi, Min Kim
Journal of the Korean Ophthalmological Society.2021; 62(6): 798. CrossRef Incidence and Clinical Features of Rhegmatogenous Retinal Detachment After 9,484 Intravitreal Injections by a Single Physician
Jae Yong Han, Hyun Goo Kang, Eun Young Choi, Sung Chul Lee, Min Kim
Journal of Retina.2020; 5(2): 79. CrossRef What is presbyopia?
Ji-Won Kwon
Journal of the Korean Medical Association.2019; 62(12): 608. CrossRef Comparison of Clinical Outcomes between Laser Blended Vision and Monovision Laser Refractive Surgery for Presbyopia
Suchan Lee, Cheolwon Jang, Seok Joon Kong, Jae Woo Kim, Young Joo Cho, Tae Hyung Lim, Kee Yong Choi, Beom Jin Cho
Journal of the Korean Ophthalmological Society.2016; 57(12): 1840. CrossRef
|